About: Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. Its lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, chikungunya virus, chronic heart failure, allergic respiratory, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is headquartered in Melbourne, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.29 (+5.56%)
PARASXParadigm Biopharmaceuticals Ltd
Paradigm Biopharmaceuticals Ltd share price
PAR price activity
Último preço
$ 0,290
Variação (24h)
0,02 AUD (5,56%)
Volume
4.08M
Volume (média 4 sem.)
-
Abertura
$ 0,27
Variação do dia
$ 0,25 - $ 0,29
Fechamento anterior
$ 0,27
Último negócio
10 Sep, 6:10 am GMT+0
Atrasado
10 Sep, 6:10 am GMT+0
PAR price performance
Atrasado
10 Sep, 6:10 am GMT+0
quote.marketSignals